Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 7—July 2010


Mycobacterium conceptionense Infection after Breast Implant Surgery, France

Sandrine Thibeaut, Pierre-Yves Levy, Marie-Laure Pelletier, and Michel DrancourtComments to Author 
Author affiliations: Université de la Méditerranée, Marseille, France (S. Thibeaut, P.-Y. Levy, M. Drancourt); Clinique la Casamance, Aubagne, France (P.-Y. Levy, M.-L. Pelletier)

Main Article


Three cases of Mycobacterium conceptionense infection in female patients*

Patient age, y Clinical situation Identification Treatment
Nature Duration, mo
31 Posttraumatic osteitis 16S rRNA, soda, hsp65, recA, rpoB Antimicrobial drug therapy: AMC 3 (4)
43 Subcutaneous abscess without trauma partial 1,464-bp 16S rRNA gene‡ Surgery and antimicrobial drug therapy: COT and CLA; then DOX and CLA; then LIN and CLA 5 (10)
58 Breast implant infection rpo Surgery and antimicrobial drug therapy: CIP and AZY; then CIP, AZY, and DOX; then DOX 18 This report

*AMC, amoxicillin/clavulanic acid; COT, cotrimoxazole; CLA, clarithromycin; DOX, doxycycline; LIN, linezolid; CIP, ciprofloxacin, AZY, azythromycin. The outcome for all 3 patients was favorable.
†GenBank accession nos.: 16S rRNA, AY859684; rpoB, AY859695; hsp65, AY859678; sodA, AY859708; recA, AY859690.
‡GenBank accession no. AM884289.1.
§GenBank accession no. AY859695.1.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO